{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:33:06Z","timestamp":1785537186915,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"American Academy of Optometry Career Development Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10633-018-9632-3","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T11:10:59Z","timestamp":1524568259000},"page":"213-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Retinal dysfunction in a presymptomatic patient with Huntington\u2019s disease"],"prefix":"10.1007","volume":"136","author":[{"given":"Jonelle","family":"Knapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"VanNasdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Racine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"issue":"1","key":"9632_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"9632_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","volume":"33","author":"P Dayalu","year":"2015","unstructured":"Dayalu P, Albin RL (2015) Huntington disease: pathogenesis and treatment. Neurol Clin 33(1):101\u2013114. \n                    https:\/\/doi.org\/10.1016\/j.ncl.2014.09.003","journal-title":"Neurol Clin"},{"key":"9632_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-3560-4_10","volume-title":"Immunotherapy and biomarkers in neurodegenerative disorders","author":"A Messer","year":"2016","unstructured":"Messer A (2016) Immunotherapy on experimental models for Huntington\u2019s Disease. In: Ingelsson M, Lannfelt L (eds) Immunotherapy and biomarkers in neurodegenerative disorders. Springer, New York, pp 139\u2013150. \n                    https:\/\/doi.org\/10.1007\/978-1-4939-3560-4"},{"issue":"9557","key":"9632_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. The Lancet 369(9557):218\u2013228. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(07)60111-1","journal-title":"The Lancet"},{"key":"9632_CR5","volume-title":"Neurobiology of Huntington\u2019s disease: applications to drug discovery","author":"DC Lo","year":"2011","unstructured":"Lo DC, Hughes RE (2011) Neurobiology of Huntington\u2019s disease: applications to drug discovery. CRC Press\/Taylor & Francis Group, Boca Raton"},{"issue":"4","key":"9632_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410340411","volume":"34","author":"W Paulus","year":"1993","unstructured":"Paulus W, Schwartz G, Werner A, Lange H, Bayer A, Hofschuster M, M\u00fcller N, Zrenner E (1993) Impairment of retinal increment thresholds in Huntington\u2019s disease. Ann Neurol 34(4):574\u2013578. \n                    https:\/\/doi.org\/10.1002\/ana.410340411","journal-title":"Ann Neurol"},{"issue":"26","key":"9632_CR7","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/hmg\/11.26.3351","volume":"11","author":"D Helmlinger","year":"2002","unstructured":"Helmlinger D, Yvert G, Picaud S, Merienne K, Sahel J, Mandel JL, Devys D (2002) Progressive retinal degeneration and dysfunction in R6 Huntington\u2019s disease mice. Hum Mol Genet 11(26):3351\u20133359. \n                    https:\/\/doi.org\/10.1093\/hmg\/11.26.3351","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9632_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.nbd.2011.12.004","volume":"45","author":"AH Batcha","year":"2012","unstructured":"Batcha AH, Greferath U, Jobling AI et al (2012) Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodeling in the R6\/1 mouse model of Huntington\u2019s disease. Neurobiol Dis 45(3):887\u2013896. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2011.12.004","journal-title":"Neurobiol Dis"},{"issue":"12","key":"9632_CR9","doi-asserted-by":"publisher","first-page":"e113317","DOI":"10.1371\/journal.pone.0113317","volume":"9","author":"S Ragauskas","year":"2014","unstructured":"Ragauskas S, Leinonen H, Puranen J et al (2014) Early retinal function deficit without prominent morphological changes in the R6\/2 mouse model of Huntington\u2019s disease. PLoS ONE 9(12):e113317. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0113317","journal-title":"PLoS ONE"},{"issue":"2","key":"9632_CR10","doi-asserted-by":"publisher","first-page":"e56026","DOI":"10.1371\/journal.pone.0056026","volume":"8","author":"M Li","year":"2013","unstructured":"Li M, Yasumura D, Ma AA et al (2013) Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of Huntington disease. PLoS ONE 8(2):e56026. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0056026","journal-title":"PLoS ONE"},{"issue":"1","key":"9632_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG et al (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1\u201312. \n                    https:\/\/doi.org\/10.1007\/s10633-014-9473-7","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"9632_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-011-9296-8","volume":"124","author":"DC Hood","year":"2012","unstructured":"Hood DC, Bach M, Brigell M et al (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124(1):1\u201313. \n                    https:\/\/doi.org\/10.1007\/s10633-011-9296-8","journal-title":"Doc Ophthalmol"},{"key":"9632_CR13","first-page":"19","volume":"4","author":"I Bodis-Wollner","year":"1989","unstructured":"Bodis-Wollner I, Marx MS, Ghilardi MF (1989) Systemic haloperidol administration increases the amplitude of the light- and dark-adapted flash ERG in the monkey. Clin Vis Sci 4:19\u201326","journal-title":"Clin Vis Sci"},{"issue":"13","key":"9632_CR14","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1167\/iovs.11-7874","volume":"52","author":"SB Varghese","year":"2011","unstructured":"Varghese SB, Reid JC, Hartmann EE, Keyser KT (2011) The effects of nicotine on the human electroretinogram. Investig Ophthalmol Vis Sci 52(13):9445\u20139451. \n                    https:\/\/doi.org\/10.1167\/iovs.11-7874","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"9632_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1442-9071.2006.01384.x","volume":"35","author":"FC Gundogan","year":"2007","unstructured":"Gundogan FC, Erdurman C, Durukan AH, Sobaci G, Bayraktar MZ (2007) Acute effects of cigarette smoking on multifocal electroretinogram. Clin Exp Ophthalmol 35(1):32\u201337. \n                    https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01384.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"9632_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/add.12410","volume":"109","author":"ML Goniewicz","year":"2014","unstructured":"Goniewicz ML, Hajek P, McRobbie H (2014) Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 109(3):500\u2013507. \n                    https:\/\/doi.org\/10.1111\/add.12410","journal-title":"Addiction"},{"issue":"5","key":"9632_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-005-1092-7","volume":"110","author":"E Petrasch-Parwez","year":"2005","unstructured":"Petrasch-Parwez E, Saft C, Schlichting A et al (2005) Is the retina affected in Huntington disease? Acta Neuropathol 110(5):523\u2013525. \n                    https:\/\/doi.org\/10.1007\/s00401-005-1092-7","journal-title":"Acta Neuropathol"},{"key":"9632_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1212\/WNL.28.1.95","volume":"28","author":"C Ellenberger","year":"1978","unstructured":"Ellenberger C, Petro DJ, Ziegler SB (1978) The visually evoked potential in Huntington disease. Neurology 28:95\u201397","journal-title":"Neurology"},{"key":"9632_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0013-4694(84)90169-X","volume":"57","author":"RC Josiassen","year":"1983","unstructured":"Josiassen RC, Shagass C, Mancall EL, Roemer RA (1983) Auditory and visual evoked potentials in Huntington\u2019s disease. Electroencephalogr Clin Neurophysiol 57:113\u2013118. \n                    https:\/\/doi.org\/10.1016\/0013-4694(84)90169-X","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"3","key":"9632_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/JHD-170255","volume":"6","author":"JR Pearl","year":"2017","unstructured":"Pearl JR, Heath LM, Bergey DE et al (2017) Enhanced retinal responses in Huntington\u2019s disease patients. J Huntington\u2019s Dis 6(3):237\u2013247. \n                    https:\/\/doi.org\/10.3233\/jhd-170255","journal-title":"J Huntington\u2019s Dis"},{"issue":"11","key":"9632_CR21","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","volume":"262","author":"HM Kersten","year":"2015","unstructured":"Kersten HM, Danesh-Meyer HV, Kilfoyle DH, Roxburgh RH (2015) Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression. J Neurol 262(11):2457\u20132465. \n                    https:\/\/doi.org\/10.1007\/s00415-015-7869-2","journal-title":"J Neurol"},{"key":"9632_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0896-6273(00)80573-5","volume":"21","author":"GR Jackson","year":"1998","unstructured":"Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW, MacDonald ME, Zipursky SL (1998) Polyglutamine-expanded human huntingtin transgene induce changes of Drosophila photoreceptor neurons. Neuron 21:633\u2013642","journal-title":"Neuron"},{"key":"9632_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nbd.2015.05.008","volume":"80","author":"A Karam","year":"2015","unstructured":"Karam A, Tebbe L, Weber C et al (2015) A novel function of huntingtin in the cilium and retinal ciliopathy in Huntington\u2019s disease mice. Neurobiol Dis 80:15\u201328. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2015.05.008","journal-title":"Neurobiol Dis"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-018-9632-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-018-9632-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-018-9632-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T19:13:22Z","timestamp":1556046802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-018-9632-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["9632"],"URL":"https:\/\/doi.org\/10.1007\/s10633-018-9632-3","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"Informed consent was obtained from all participants in this study. Additional informed consent was obtained from the participant for whom identifying information is included in this article and he consented to the submission of this case report to the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"There were no tests on animals in this case report.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}